Stock listing

Novo Nordisk A/s Class B

Selected listing: 866931 · LSX · EUR · DE

Novo Nordisk A/s Class B (LS Exchange: 866931), Health Technology. Latest release Sep 29, 2026: Novo and Hengrui Pharma enter exclusive license agreement…

866931:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: 866931
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Novo Nordisk A/s Class B

Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596

September 29, 2026

Highlights to be presented at Novo’s Capital Markets Day 2026

September 21, 2026

Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture

September 14, 2026

Novo Nordisk A/S: IT Security incident at Novo Nordisk

June 11, 2026

Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK

June 11, 2026

All Novo Nordisk A/s Class B news →

Events

Replays

Novo Nordisk A/S (NVO) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 07:00 AM ET
Watch
Novo Nordisk A/S (NVO) Q1 2026 Earnings Call
Wed, May 06, 2026 · 07:00 AM ET
Watch
Novo Nordisk A/S (NVO) Q4 2025 Earnings Call
Wed, Feb 04, 2026 · 07:00 AM ET
Watch

Research Novo Nordisk A/s Class B

Novo Nordisk A/s Class B company profile

View the public company page for Novo Nordisk A/s Class B on 6ix.

Novo Nordisk A/s Class B news

Read company news and market updates connected to Novo Nordisk A/s Class B.

Novo Nordisk A/s Class B investor events

Find investor webinars, events, and replay context for Novo Nordisk A/s Class B.